Inhibition of autocrine IGF-II on effect of human HepG2 cell proliferation and angiogenesis factor expression

References

Page 1

	Year	Citations
Global cancer statistics Ahmedin Jemal, Freddie Bray CA A Cancer Journal for Clinicians	2011	55K
A vision for the future of genomics research Francis S. Collins, Eric D. Green, Alan E. Guttmacher, Nature Functional GenomicsNext-generation SequencingGeneticsComputational GenomicsComputational Biology	2003	1.7K
Multiple Signaling Pathways of the Insulin-Like Growth Factor 1 Receptor in Protection from Apoptosis Francesca Peruzzi, Marco di Prisco, Michael Dews, Molecular and Cellular Biology Multiple Signaling PathwaysType 1Signal TransductionSignaling PathwayMitochondrial Translocation	1999	501
Aberrant methylation of multiple tumor suppressor genes in aging liver, chronic hepatitis, and hepatocellular carcinoma Naoshi Nishida, Takeshi Nagasaka, Takafumi Nishimura, Hepatology	2007	288
Comparison of different antisense strategies in mammalian cells using locked nucleic acids, 2'-O-methyl RNA, phosphorothioates and small interfering RNA Arnold Grünweller Nucleic Acids Research ChromatinLocked Nucleic AcidsLna GapmerMedicineNatural Sciences	2003	268
Insulin receptor functionally enhances multistage tumor progression and conveys intrinsic resistance to IGF-1R targeted therapy Danielle Ulanet, Dale L. Ludwig, C. Ronald Kahn, Proceedings of the National Academy of Sciences	2010	232
IGF activation in a molecular subclass of hepatocellular carcinoma and pre-clinical efficacy of IGF-1R blockage Victoria Tovar, Clara Alsinet, Augusto Villanueva, Journal of Hepatology HepatologyIgf-1r BlockageLiver PhysiologyPathologyLiver Cancer	2010	220
Differential expression of insulin-like growth factor II mRNA in human primary liver cancers, benign liver tumors, and liver cirrhosis. Elisabetta Cariani, Cantal Lasserre, Danielle Seurin, PubMed PathologyLiver CarcinogenesisTumor BiologyHepatobiliary TumorCancer Cell Biology	1988	193
Insulin-like growth factor II induced by hypoxia may contribute to angiogenesis of human hepatocellular carcinoma. Kyu‐Won Kim, Soo Kyung Bae, Ok‐Hee Lee, PubMed Human Hepatocellular CarcinomaPathologyTumor BiologyAngiogenesisCancer Cell Biology	1998	190
The Insulin-like Growth Factor-1 Receptor–Targeting Antibody, CP-751,871, Suppresses Tumor-Derived VEGF and Synergizes with Rapamycin in Models of Childhood Sarcoma Raushan T. Kurmasheva, Lorina Dudkin, Catherine A. Billups, Cancer Research	2009	149

Page 1